Login
$PVCT
$0.06 +$0.00 (3.9%) Close

Ownership

13F as of Q2 2026 · 420.3M shares outstanding

Who owns PVCT?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 6 holders own 18.5%
Pershing Edward 12.5% · Dominic Rodrigues 6.0%
Institutional ownership
0.0%
-0.0 pts vs last qtr
Institutional holders
4
-1 vs last qtr
Net shares bought
−52.6K
by institutions in Q2 2026
New / sold out
0 / 1
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • Wealth Preservation Advisors, LLC SOLD OUT −52.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Provectus Biopharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+0.2%
+0.06% a year
Each share's claim on the business
−0.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $2.52M
over 4 fiscal years
Diluted shares, split-adjusted
406.9M415.7M424.5M2022: 419.5M shares'222023: 419.5M shares'232024: 419.8M shares'242025: 420.3M shares'25
Buybacks Stock-based comp
$0$640.4K$1.3M2022 buybacks: $02022 stock comp: $3.0K'222023 buybacks: $02023 stock comp: $2.9K'232024 buybacks: $02024 stock comp: $1.3M'242025 buybacks: $02025 stock comp: $1.2M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years77% 3–5 years0% 1–3 years8% Under 1 year15%
Quarterly turnover
14.4%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting PVCT on Form 13F
HF
Home Federal Bank Of Tennessee
Shares
100.0K
% of company
0.02%
Change vs last qtr
Unchanged
Held since
≤2021
WP
Wealth Preservation Advisors, LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

3 more super investors behind a free account

See every manager holding Provectus Biopharmaceuticals Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting PVCT on Form N-PORT; together they hold 0.0% of the company
No fund reports holding PVCT yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
PE
Pershing Edward
5%+ holder13D · 11.6%
Shares
52.4M
% of company
12.48%
Change vs last qtr
—
Held since
—
DR
Dominic Rodrigues
5%+ holder13D · 5.7%
Shares
25.2M
% of company
6.00%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support